Related Experiment Video

Updated: Dec 3, 2025

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

7.6K

Hemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology

Mélanie Gaubert1, Marc Laine1, Noémie Resseguier2

  • 1Cardiology Department, APHM, Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), Centre for CardioVascular and Nutrition Research (C2VN), Aix-Marseille Univ, INSERM 1263, INRA 1260, Hopital Nord, 13015 Marseille, France.

Journal of Clinical Medicine
|October 27, 2020
PubMed

Insights

Cardiogenic shock (CS) patients have different hemodynamic profiles based on the cause. Acute myocardial infarction CS shows lower systemic vascular resistance and higher cardiac index compared to acute decompensated chronic heart failure CS.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Hemodynamics

Background:

  • Cardiogenic shock (CS) pathophysiology differs by etiology, influencing hemodynamic profiles (HP) and treatment strategies.
  • Understanding these variations is crucial for optimizing patient management and therapeutic interventions.

Purpose of the Study:

  • To compare the hemodynamic profiles of CS patients with acute myocardial infarction (AMI) versus acute decompensated chronic heart failure (ADCHF).
  • To determine if distinct HP warrant tailored therapeutic approaches based on CS etiology.

Main Methods:

  • Prospective inclusion of 28 CS patients with either AMI or ADCHF.
  • Measurement of Systemic Vascular Resistance index (SVRi), Cardiac Index (CI), and Cardiac Power Index (CPI) via trans-thoracic Doppler echocardiography before inotropic or vasopressor administration.

Main Results:

  • CS secondary to AMI exhibited significantly lower SVRi (2010 vs. 2622 dynes-s·cm-5·m-2, p=0.002) compared to ADCHF.
  • A trend towards a higher CI was observed in AMI CS (2.13 vs. 1.78 L·min-1·m-2, p=0.067).
  • Demographics and shock severity were comparable between the two groups.

Conclusions:

  • Significant differences in hemodynamic profiles exist between CS caused by AMI and ADCHF.
  • These distinct HP, particularly lower SVRi and higher CI in AMI CS, should inform patient selection for future clinical research and guide therapeutic strategies.

Keywords:
acute decompensated heart failureacute myocardial infarctioncardiogenic shockhemodynamic evaluation

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

902

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
441
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
303
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
224